The Lancet Pulse

Are we on the cusp of a psychedelic renaissance in psychiatry?

The Lancet

Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.

0:00 | 49:03

Professor Rachel Yehuda from the Icahn School of Medicine at Mount Sinai describes psychedelics as “heart openers” and Dr. Liliana Galindo from the University of Cambridge likens their action to a surgeon’s scalpel, but each agree that psychedelic-assisted therapy may offer lasting relief to people struggling with a wide range of mental health problems. 

Both join Lancet editors Jonathan and Matt to discuss the burgeoning field of psychedelic-assisted therapy. LSD, MDMA, 5-MeO-DMT, psilocybin, anxiety, depression, eating disorders, substance-use disorders, post-traumatic stress disorder; potentially-pivotal phase 3 trial data are maturing amid growing interest from regulators and investors, but many practical questions remain before the patients most in need may benefit from this psychedelic renaissance.

---------------------------------

The Lancet Pulse is part of the Lancet Group podcast offering. 

Editorial team: Chloe Wilson, Ben Abbott, Matthew Gilbert, and Jonathan Pimm

Podcast editing and production: Matteo Simonetti

Visit https://www.thelancet.com/multimedia to learn more about our multimedia offering. 

Find the best science for better lives at https://www.thelancet.com

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv